, Infectious Diseases Department, Gustave Dron Hospital of Tourcoing, 135 rue du Président Coty, 59200 Tourcoing, France. 4 Unit of Infectious Diseases Hospital 12 de Octubre of Madrid
, 12 Orthopaedic Surgery Unit, University Hospital of Caen, Orthopaedic Surgery Unit, p.14
, Faculty Hospital of Lille
Prosthetic-joint infections, N Engl J Med, vol.351, pp.1645-54, 2004. ,
Irrigation and debridement for periprosthetic infections: does the organism matter?, J Arthroplasty, vol.26, pp.114-122, 2011. ,
Outcome of penicillin susceptible streptococcal prosthetic joint infection treated with debridement and retention of the prosthesis, Clin Infect Dis, vol.36, pp.845-894, 2003. ,
Successful antimicrobial therapy and implant retention for streptococcal infection of prosthetic joints, ANZ J Surg, vol.74, pp.210-224, 2004. ,
Increased risk of joint failure in hip prostheses infected with Staphylococcus aureus with debridement, antibiotics and implant retention compared to Streptococcus spp, Int Orthop, vol.39, pp.397-401, 2015. ,
Outcome of group B streptococcal prosthetic hip infections compared to that of other bacterial infections, Jt Bone Spine Rev Rhum, vol.76, pp.491-497, 2009. ,
Infectious Diseases Society of America. Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America, Clin Infect Dis, vol.56, pp.1-10, 2013. ,
Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response, Antimicrob Agents Chemother, vol.34, pp.1865-1873, 1990. ,
Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group, JAMA, vol.279, pp.1537-1578, 1998. ,
Effectiveness and safety of rifampicin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention, Eur J Clin Microbiol Infect Dis, vol.29, pp.961-968, 2010. ,
Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus, Clin Infect Dis, vol.53, pp.334-374, 2011. ,
A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention, Clin Infect Dis, vol.56, p.182194, 2013. ,
Prosthetic joint infection: new developments in diagnosis and treatment, Dtsch Med Wochenschr, vol.138, pp.1571-1574, 2013. ,
Diffusion in bone tissue of antibiotics, Presse Med, vol.28, pp.2265-76, 1999. ,
Rifampicin combination therapy for nonmycobacterial infections, Clin Microbiol Rev, vol.23, pp.14-34, 2010. ,
, Proceedings of the International Consensus on Periprosthetic Joint Infection, vol.95, pp.1450-1452, 2013.
Effectiveness of ciprofloxacin or linezolid in combination with rifampicin against Enterococcus faecalis in biofilms, J Antimicrob Chemother, vol.67, pp.433-442, 2012. ,
Pathogen-driven decision for implant retention in the management of infected total knee prostheses, Int Orthop, vol.37, pp.1471-1476, 2013. ,
BGS PJI study group. Group B streptococcus in prosthetic hip and knee joint-associated infections, J Hosp Infect, vol.79, pp.64-73, 2011. ,
Group B streptococcal prosthetic joint infections, J South Orthop Assoc, vol.10, pp.209-223, 2001. ,
Characteristics of prosthetic joint infections due to Enterococcus sp and predictors of failure: a multi-national study, European Society Group of Infections on Artificial Implants (ESGIAI), vol.11, pp.1219-1243, 2014. ,
Antibacterial activity of various antibiotics against oral streptococci isolated in the oral cavity, Int J Immunopathol Pharmacol, vol.25, pp.805-814, 2012. ,
Rifampicin, a useful drug for nonmycobacterial infections, Pharmacotherapy, vol.18, pp.345-57, 1998. ,
The preoperative prediction of success following irrigation and debridement with polyethylene exchange for hip and knee prosthetic joint infections, J Arthroplasty, vol.27, pp.757-854, 2012. ,
Efficacy of debridement in hematogenous and early post-surgical prosthetic joint infections, Int J Artif Organs, vol.34, pp.863-872, 2011. ,
Acute haematogenous prosthetic joint infection: prospective evaluation of medical and surgical management, Clin Microbiol Infect, vol.16, pp.1789-95, 2010. ,
, Osteo-articular infection therapy according to materials used (prosthesis, implants, osteosynthesis)
, Groupe de Pathologie Infectieuse Pédiatrique (GPIP
, Société Française d'Anesthésie et de Réanimation (SFAR)
, Chirurgie Orthopédique et Traumatologique (SOFCOT
, Société Française d'Hygiène Hospitalière (SFHH)
, Société Française de Médecine Physique et de Réadaptation (SOFMER)
, Société Française de Microbiologie (SFM
, Société rançaise de Rhumatologie, vol.39, pp.745-74, 2009.
Influence of daily dosage and frequency of administration of rifampicinlevofloxacin therapy on tolerance and effectiveness in 154 patients treated for prosthetic joint infections, Eur J Clin Microbiol Infect Dis, vol.4, pp.1675-82, 2015. ,
Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus, J Antimicrob Chemother, vol.33, pp.959-67, 1994. ,